These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8809962)

  • 21. Immunosuppressants and alloimmunization against red blood cell transfusions.
    Zalpuri S; Evers D; Zwaginga JJ; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG
    Transfusion; 2014 Aug; 54(8):1981-7. PubMed ID: 24689865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibody formation after alloimmunization inducing bystander immune hemolysis.
    Mota M; Bley C; Aravechia MG; Hamerschlak N; Sakashita A; Kutner JM; Castiho L
    Immunohematology; 2009; 25(1):9-12. PubMed ID: 19856726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transfusion management of patients with red blood cell antibodies].
    Bujandrić NB; Grujić JN; Krga-Milanović MM
    Med Pregl; 2013; 66(11-12):491-6. PubMed ID: 24575638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes.
    Michail-Merianou V; Pamphili-Panousopoulou L; Piperi-Lowes L; Pelegrinis E; Karaklis A
    Vox Sang; 1987; 52(1-2):95-8. PubMed ID: 3300026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttransfusion purpura following bone marrow transplantation.
    Evenson DA; Stroncek DF; Pulkrabek S; Perry EH; Radford J; Miller JS; Verfaillie C
    Transfusion; 1995 Aug; 35(8):688-93. PubMed ID: 7631411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Red cells, HLA and platelet antibody formation in patients with multiple transfusions.
    Chow MP; Hu HY; Lyou JY; Lin JS; Yung CH; Lee A; Lee TD
    Acta Haematol; 1994; 92(2):57-60. PubMed ID: 7817704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new case of allo-anti-LWab].
    Taliano V; Fleury M; Decary F
    Rev Fr Transfus Hemobiol; 1989 Oct; 32(5):337-43. PubMed ID: 2619842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
    Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
    Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of red blood cells filtered through cotton wool to prevent antileukocyte antibody production in multitransfused patients.
    Sirchia G; Parravicini A; Rebulla P; Greppi N; Scalamogna M; Morelati F
    Vox Sang; 1982; 42(4):190-7. PubMed ID: 7046247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A pregnant woman with irregular erythrocyte antibodies for whom no compatible packed red blood cells were available].
    Boonstra JG; Overbeeke MA; de Rijke YB; Duvekot JJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2633-6. PubMed ID: 16355577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
    Irani MS; Karafin MS; Ernster L
    J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Dob implicated as the cause of a delayed hemolytic transfusion reaction.
    Moheng MC; McCarthy P; Pierce SR
    Transfusion; 1985; 25(1):44-6. PubMed ID: 3969700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Severe bleeding in a patient with anti-c alloantibodies and a rare Rhesus phenotype treated with compatible erythrocyte concentrate from the blood bank of the Council of Europe].
    Sonke GS; Overbeeke MA; de Graaff WE; Elisen MG
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2628-32. PubMed ID: 16355576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotinylation modifies red cell antigens.
    Cowley H; Wojda U; Cipolone KM; Procter JL; Stroncek DF; Miller JL
    Transfusion; 1999 Feb; 39(2):163-8. PubMed ID: 10037126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporary suppression of Kidd system antigen expression accompanied by transient production of anti-Jk3.
    Issitt PD; Obarski G; Hartnett PL; Wren MR; Prewitt PL
    Transfusion; 1990 Jan; 30(1):46-50. PubMed ID: 2296791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Oka antigen and anti-Oka].
    Tsubaki Y
    Nihon Rinsho; 1999 Nov; 57 Suppl():625-6. PubMed ID: 10635931
    [No Abstract]   [Full Text] [Related]  

  • 39. [Alloimmunization in poly-transfused patients with hemoglobin S disease].
    Gómez Oliva P; Basanta Otero P; González Villalonga C; Batista Veranes M; Orbeal Aldama L; García Echevarría M
    Sangre (Barc); 1985; 30(4-A):406-10. PubMed ID: 4071354
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-Ge2 in a Ge: -2, -3 patient].
    Durán-Suárez JR; Sánchez C; Herrero E; Hernández Sánchez JM
    Sangre (Barc); 1991 Aug; 36(4):319-21. PubMed ID: 1776112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.